{"id":870267,"date":"2025-08-04T16:01:27","date_gmt":"2025-08-04T20:01:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/"},"modified":"2025-08-04T16:01:27","modified_gmt":"2025-08-04T20:01:27","slug":"shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/","title":{"rendered":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Aug.  04, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Go8P7I8EIYLX0xXx_20v8mgmoSeCBTJr0a-0Vt-RIzkxuve2XWg-mA_oTiz3gA4E-CruToR2anikyAD4vKNQfHGR37cLgS9kUw98u9-n5sRNN_Peq4C36UxfEcSj6gviP9CWqCyRE8Mhdqq6W1ERgUfIIvDEZATJ5sLuK8WZGrdvklpgB6l69bwJtw3Lmv0L\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a> announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of\u00a0Replimune Group, Inc. (NASDAQ: REPL) (\u201cReplimune\u201d or the \u201cCompany\u201d)<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3RpqXKIHEBa4p6jyhG1rRCJbgO_reW8_lowqbERRS9o4vSpF01Ne90HRn0I9tcwhxtOh6dk7SEcdeWhIGlVGsovNYLECKj0IKI1XlMeWGqiIhhO_0-c6z1uO6XvwEYtMJhGNpH1DJZ7H5xZTrhiYZMII3lMaWPQMU5llS6mP4Ca2e4tTXshz83Brb5tNreKPbyhQYr5MJHGKFIsbuj3fYw==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <strong>Class Action Details:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Case Filed:<\/strong> A class action lawsuit has been filed against <strong>Replimune Group, Inc.<\/strong> (NASDAQ: REPL) alleging possible securities fraud or other unlawful business practices by the company and certain officers\/directors.<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Jurisdiction<\/strong>: United States District Court for the District of Massachusetts<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Class Period<\/strong>: November 22, 2024 \u2013 July 21, 2025<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Lead Plaintiff Deadline:<\/strong> Investors who bought Replimune shares during the relevant period have until <strong>September 22, 2025<\/strong> to ask the Court to appoint them as Lead Plaintiff.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Trigger Event:<\/strong><br \/>\n          <a href=\"https:\/\/www.onclive.com\/view\/fda-issues-crl-for-rp1-plus-nivolumab-for-advanced-melanoma\" rel=\"nofollow\" target=\"_blank\">On <strong>July 22, 2025<\/strong>, the <strong>FDA issued a Complete Response Letter (CRL)<\/strong><\/a> rejecting Replimune\u2019s Biologics License Application (BLA) for <strong>RP1<\/strong> (vusolimogene oderparepvec) combined with nivolumab to treat advanced melanoma. <\/p>\n<ul type=\"circle\">\n<li style=\"margin-bottom:8pt;text-align:justify\">The <strong>FDA found<\/strong> that the <strong>IGNYTE trial<\/strong> did not provide <strong>adequate or well-controlled clinical evidence<\/strong> of effectiveness.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">The trial\u2019s results were deemed uninterpretable due to <strong>patient heterogeneity<\/strong>, and the <strong>confirmatory study design<\/strong> needs revisions.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\"><strong>No safety concerns<\/strong> were raised.<\/li>\n<\/ul>\n<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">\n          <strong>Market Reaction:<\/strong> Following this news, Replimune\u2019s stock <strong>plummeted by 77.24%<\/strong>, dropping <strong>$9.52<\/strong> to close at <strong>$2.81 per share<\/strong> on the same day.<\/p>\n<\/li>\n<\/ul>\n<p>\n        <strong>Why\u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Go8P7I8EIYLX0xXx_20v8mgmoSeCBTJr0a-0Vt-RIzkxuve2XWg-mA_oTiz3gA4El3N6vlRTWFoNhOgOM_75pTXwbDyBCxRTw1Wx7LEe27Htm502t95WsXcIDvdsZM8Cu0noSYH8VjniHfxXOUANDFXLh3rsvwx-CANDbCmDoDvouNCB7mKr7APupDLSiTfS\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong><br \/>\n            <u>Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/u><br \/>\n          <\/strong><br \/>\n        <\/a><br \/>\n        <strong>?<\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">This illustrious <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V5-eAoUEZyx5jqWbMADVUjQL4ECN25tI73ZO96UBBWsfI8x8Fhvu7OX5p2_AaAd83Et6Oybi7CdrIFzMe9Mc5Rwbazd34G41KPaB8AZHorxd-VTru7HahhrOqE6CY-yc\" rel=\"nofollow\" target=\"_blank\">firm<\/a>, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0The <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pPBkXUg7X0Yj5UrLzvVUHa4XGIQnyD1mZofUaWfd3PtK0BFgysEF3i6yCgot2XDu0H29v-6QHJBU6vyJ-fAx6Pwxzh85OH_MKKrS0MFeo9LhFtUg2Y144zFQyLA_u9VE\" rel=\"nofollow\" target=\"_blank\">law firm\u00a0<\/a>brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p align=\"justify\">We encourage all investors who have been affected or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Go8P7I8EIYLX0xXx_20v8mgmoSeCBTJr0a-0Vt-RIzkxuve2XWg-mA_oTiz3gA4EHaYQESlN07Wp7LbAQcR6OM1uqrroUgxEhIhOJ70oKqFDzHK0C2Pe5Mf8GexNwLIXy9TRvWvinl3J8yZMRx4G0TEdhxUNqF8HhhJ9Sl1ZHgA1boYLdXk9MrRIsm8wEJXD\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Phone:<\/strong>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Email:\u00a0<\/strong><br \/>\n          <a href=\"mailto:classmember@whafh.com\" rel=\"nofollow\" target=\"_blank\">classmember@whafh.com<\/a>\n        <\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Contact Person:<\/strong>\u00a0<a href=\"mailto:gstone@whafh.com\" rel=\"nofollow\" target=\"_blank\">Gregory Stone, Director of Case and Financial Analysis<\/a><\/p>\n<\/li>\n<\/ul>\n<p>\n        <strong>Firm Website:<\/strong>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Go8P7I8EIYLX0xXx_20v8mgmoSeCBTJr0a-0Vt-RIzkxuve2XWg-mA_oTiz3gA4E2O6SRv11umoqp0sxevhGR5Si3ImbzlArgA1g7_KREW6PZ0xxgtAwnHNbSPIFt9QS8hZSkvJfFidi3Nw20eC_ZpzrLCeblW2RHwh2hyiqw_s0rKn0Ya8VzAsX757KtKJQ\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDZhZTQ4NTgtNTY2Zi00NjM5LWE2ZmEtYTkyMmY1YmRjMGUwLTEwMjkyNDItMjAyNS0wOC0wNC1lbg==\/tiny\/Wolf-Haldenstein-Adler-Freeman.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of\u00a0Replimune Group, Inc. (NASDAQ: REPL) (\u201cReplimune\u201d or the \u201cCompany\u201d) PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Action Details: Case Filed: A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) alleging possible securities fraud or other unlawful business practices by the company and certain officers\/directors. Jurisdiction: United States District Court for the District of Massachusetts Class Period: November 22, 2024 \u2013 July 21, 2025 Lead Plaintiff Deadline: Investors who bought Replimune shares during the relevant period have &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870267","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of\u00a0Replimune Group, Inc. (NASDAQ: REPL) (\u201cReplimune\u201d or the \u201cCompany\u201d) PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Action Details: Case Filed: A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) alleging possible securities fraud or other unlawful business practices by the company and certain officers\/directors. Jurisdiction: United States District Court for the District of Massachusetts Class Period: November 22, 2024 \u2013 July 21, 2025 Lead Plaintiff Deadline: Investors who bought Replimune shares during the relevant period have &hellip; Continue reading &quot;Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T20:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd\",\"datePublished\":\"2025-08-04T20:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/\"},\"wordCount\":371,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/\",\"name\":\"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\",\"datePublished\":\"2025-08-04T20:01:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk","og_description":"NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed\u00a0on behalf of all persons or entities who purchased the securities of\u00a0Replimune Group, Inc. (NASDAQ: REPL) (\u201cReplimune\u201d or the \u201cCompany\u201d) PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Action Details: Case Filed: A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) alleging possible securities fraud or other unlawful business practices by the company and certain officers\/directors. Jurisdiction: United States District Court for the District of Massachusetts Class Period: November 22, 2024 \u2013 July 21, 2025 Lead Plaintiff Deadline: Investors who bought Replimune shares during the relevant period have &hellip; Continue reading \"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-04T20:01:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd","datePublished":"2025-08-04T20:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/"},"wordCount":371,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/","name":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=","datePublished":"2025-08-04T20:01:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTc5OSM3MDgwNjcwIzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-on-replimune-group-inc-nasdaq-repl-should-contact-wolf-haldenstein-immediately-as-lead-plaintiff-deadline-is-september-22nd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870267"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870267\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}